Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

AdaptHealth (AHCO) Change in Accured Expenses (2018 - 2026)

AdaptHealth has reported Change in Accured Expenses over the past 8 years, most recently at $27.5 million for Q4 2025.

For Q4 2025, Change in Accured Expenses rose 683.96% year-over-year to $27.5 million; the TTM value through Dec 2025 reached $139.3 million, up 311.66%, while the annual FY2025 figure was $139.3 million, 311.66% up from the prior year.
Change in Accured Expenses for Q4 2025 was $27.5 million at AdaptHealth, down from $46.8 million in the prior quarter.
Over five years, Change in Accured Expenses peaked at $110.3 million in Q2 2024 and troughed at -$68.1 million in Q2 2023.
A 5-year average of $3.7 million and a median of $4.0 million in 2024 define the central range for Change in Accured Expenses.
Biggest five-year swings in Change in Accured Expenses: tumbled 473.84% in 2021 and later soared 724.76% in 2022.
Year by year, Change in Accured Expenses stood at -$1.5 million in 2021, then soared by 724.76% to $9.6 million in 2022, then surged by 576.79% to $64.7 million in 2023, then tumbled by 94.59% to $3.5 million in 2024, then surged by 683.96% to $27.5 million in 2025.
Business Quant data shows Change in Accured Expenses for AHCO at $27.5 million in Q4 2025, $46.8 million in Q3 2025, and $60.4 million in Q2 2025.